2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Triple Negative Breast Neoplasms in 5 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guney Eskiler, G | 2 |
| Ozturk, M | 1 |
| Andreidesz, K | 1 |
| Koszegi, B | 1 |
| Kovacs, D | 1 |
| Bagone Vantus, V | 1 |
| Gallyas, F | 1 |
| Kovacs, K | 1 |
| Hussain, AR | 1 |
| Siraj, AK | 1 |
| Ahmed, M | 1 |
| Bu, R | 1 |
| Pratheeshkumar, P | 1 |
| Alrashed, AM | 1 |
| Qadri, Z | 1 |
| Ajarim, D | 1 |
| Al-Dayel, F | 1 |
| Beg, S | 1 |
| Al-Kuraya, KS | 1 |
| Jung, HH | 1 |
| Lee, SH | 1 |
| Kim, JY | 1 |
| Ahn, JS | 1 |
| Park, YH | 1 |
| Im, YH | 1 |
5 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Therapeutic potential of the PI3K inhibitor LY294002 and PARP inhibitor Talazoparib combination in BRCA-deficient triple negative breast cancer cells.
Topics: BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Chromones; Female; Humans; Morpholines; Phosphati | 2022 |
The Interaction of PI3K Inhibition with Homologous Recombination Repair in Triple Negative Breast Cancer Cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Chromones; Dose-Response Relationship, Drug; D | 2019 |
Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proli | 2021 |
XIAP over-expression is an independent poor prognostic marker in Middle Eastern breast cancer and can be targeted to induce efficient apoptosis.
Topics: Adult; Aged; Animals; Apoptosis; Benzoquinones; Biomarkers, Tumor; Chromones; Female; Gene Expressio | 2017 |
Statins affect ETS1-overexpressing triple-negative breast cancer cells by restoring DUSP4 deficiency.
Topics: Antineoplastic Agents; Apoptosis; Butadienes; Cell Line, Tumor; Cell Survival; Chromones; Dual-Speci | 2016 |